| # | Drug | Count |
|---|---|---|
| 0 | COLCHICINE | 2 |
| 1 | FLUOROURACIL | 2 |
| 2 | FLUOROURACIL CREAM, 0.5% | 2 |
| 3 | OXALIPLATIN | 2 |
| 4 | RAMUCIRUMAB | 2 |
| 5 | ABROCITINIB | 1 |
| 6 | BEVACIZUMAB | 1 |
| 7 | FEBUXOSTAT | 1 |
| 8 | FEBUXOSTAT TABLETS 40 MG | 1 |
| 9 | FEBUXOSTAT TABLETS 80 MG | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | RAMUCIRUMAB | 2 | 0.0003 |
| 1 | ABROCITINIB | 1 | 0.0003 |
| 2 | FEBUXOSTAT TABLETS 40 MG | 1 | 0.0001 |
| 3 | COLCHICINE | 2 | 0.0001 |
| 4 | FEBUXOSTAT | 1 | 0.0001 |
| 5 | NIRAPARIB | 1 | 0.0000 |
| 6 | OXALIPLATIN | 2 | 0.0000 |
| 7 | FLUOROURACIL CREAM, 0.5% | 2 | 0.0000 |
| 8 | FLUOROURACIL | 2 | 0.0000 |
| 9 | TADALAFIL | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 2 | 0.0003 |
| 1 | Alkaloid [EPC] | 2 | 0.0001 |
| 2 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 1 | 0.0000 |
| 3 | Phosphodiesterase 5 Inhibitor [EPC] | 1 | 0.0000 |
| 4 | Platinum-based Drug [EPC] | 2 | 0.0000 |
| 5 | Nucleoside Metabolic Inhibitor [EPC] | 2 | 0.0000 |
| 6 | Janus Kinase Inhibitor [EPC] | 1 | 0.0000 |
| 7 | Microtubule Inhibitor [EPC] | 1 | 0.0000 |
| 8 | Xanthine Oxidase Inhibitor [EPC] | 1 | 0.0000 |
| 9 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 1 | 0.0000 |